Effects of class III antiarrhythmic drugs on transient outward and ultra-rapid delayed rectifier currents in human atrial myocytes

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 1, 1997, Pages 384-392

  Feng, Jianlin ^a   Wang, Zhiguo ^a   Gui Rong, Li ^a   Nattel, Stanley ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; AMBASILIDE; ANTIARRHYTHMIC AGENT; CATION CHANNEL; SOTALOL;

ARTICLE; CONCENTRATION RESPONSE; HEART ATRIUM; HEART DEPOLARIZATION; HUMAN; HUMAN CELL; ION CURRENT; MEMBRANE CURRENT; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; VOLTAGE CLAMP;

AMINOBENZOIC ACIDS; ANTI-ARRHYTHMIA AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART ATRIA; HUMANS; MIDDLE AGED; PIPERIDINES; POTASSIUM CHANNELS; PYRIDINES; SOTALOL;

EID: 8244250767     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. BALSER, J. R., BENNETT, P. B., HONDEGHEM, L. M. AND RODEN, D. M.: Suppression of time-dependent outward current in guinea pig ventricular myocytes. Actions of quinidine and amiodarone. Circ. Res. 69: 519-529, 1991.
2. BERGER, F., BUKCHARD, U. AND HAFNER, D.: Effects of (+)- and (±)-sotalol on repolarizing outward currents and pacemaker current in sheep cardiac Purkinje fibres. Naunyn-Schmiedeberg's Arch. Pharmacol. 340: 696-704, 1989.
3. CARMELIET, E.: Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers. J. Pharmacol. Exp. Ther. 232: 817-825, 1985.
4. COLATSKY, T. J. AND ARGENTIERI, T. M.: Potassium channel blockera as antiarrhythmic drugs. Drug Develop. Res, 33: 235-249, 1994.
5. COLATSKY, T. J., FOLLMER, C. H. AND STARMER, C. F.: Channel specificity in antiarrhythmic drug action: Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias. Circulation 82: 2235-2242, 1990.
6. CRUMB, W. J. JR., PIGOTT, J. D. AND CLARKSON, C. W.: Description of a nonselective cation current in human atrium. Circ. Res. 77: 950-956, 1995.
7. ESCANDE, D., COULOMBE, A., FAIVRE, J.-F., DEROLBAIX, E. AND CORAHOEUF, E.: Two types of transient outward currents in adult human atrial cells. Am. J. Physiol. 252: H142-H148, 1987.
8. + currents in dog atrial myocytes. Am. J. Physiol. 266: C42-C51, 1994.
9. FERMINI, B., WANG, Z., DUAN, D. AND NATTEL, S.: Differences in rate dependence of transient outward current in rabbit and human atrium. Am. J. Physiol. 263: H1747-H1754, 1992.
10. FUIJIKI, A., TANI, M., MIZUMAKI, K., SHIMONO, M. AND INOUE, H.: Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias. J. Cardiovasc. Pharmacol. 23: 374-378, 1994.
11. HONDEGHEM, L. M. AND SNYDERS, D. J.: Class III antiarrhythmic agents have a lot of potential but a long way to go: Reduced effectiveness and dangers of reverse use dependence. Circulation 81: 686-690, 1990.
12. + current by dofetilide. Circ. Res. 72: 75-83, 1993.
13. KOIDL, B., FLASPHBERGER, P., SCHAFEER, P., PELZMANN, B., BERNHARD, E., MÄCHLER, H. AND RIGLER, B.: Effects of the class III antiarrhythmic drug ambasilide on outward currents in human atrial myocytes. Naunyn-Schmiedeberg's Arch. Pharmacol. 353: 226-232, 1996.
14. + current in human ventricular myocytes, Circ. Res. 78: 689-696, 1996.
15. NATTEL, S. AND ZENG, F.-D.: Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness. J. Pharmacol. Exp. Ther. 229: 283-291, 1984.
16. RASMUSSEN, H. S., ALLEN, M. J., BLACKBURN, K. J., BUTROUS, G. S. AND DALRYMPLE, H. W.: Dofetilide, a novel class III antiarrhythmic agent. J. Cardiuvasc. Pharmacol. 20: auppl. 2. S96-S105, 1992.
17. SAGER, P. T., UPPAL, P., FOLLMER, C., ANTIMISIARIS, M., PRUITT, C. AND SINGH, B. N.: Frequency-dependent electrophysiologic effects of amiodarone in humans. Circulation 88: 1063-1071, 1993.
18. + current: Differential sensitivity to block by class III antiarrhythmic agents. J. Gen. Physiol. 96: 195-215, 1990.
19. SHIBATA, E. F., DRURY, T., REFSUM, H., ALDRETE, V. AND GILES, W.: Contributions of a transient outward current to repolarization in human atrium. Am. J. Physiol. 257: H1773-H1781, 1989.
20. SINGH, B. N. AND NADEMANEE, K.: Sotalol: A beta blocker with unique antiarrhythmic properties. Am. Heart J. 114: 121-139, 1987.
21. TAKANAKA, C., SARMA, J. S. M., AND SINGH, B. N.: Electrophysiologic effects of ambasilide (LU 47110), a novel class III antiarrhythmic agent, on the properties of isolated rabbit and canine cardiac muscle. J. Cardiovasc. Pharmacol. 19: 290-298, 1992.
22. WANG, Z., FERMINI, B. AND NATTEL, S.: Delayed rectifier outward current and repolarization in human atrial myocytes. Circ. Res. 73: 276-285, 1993a.
23. + current similar to Kv1.5 cloned channel currents. Circ. Res. 73: 1061-1076, 1993b.
24. WANG, Z., FERMINI, B. AND NATTEL, S.: Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc. Res. 28: 1540-1548, 1994a.
25. WANG, Z., FERMINI, B. AND NATTEL, S.: Effects of fiecainide, quinidine and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. J. Pharmacol. Exp. Ther. 272: 184-196. 1995.
26. WANG, J., FENG, J. AND NATTEL, S.: Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-Botalol and the new antiarrhythmic drug ambasilide. Circulation 90: 2032-2040, 1994b.
27. WANG, T., BERGSTRAND, R. H., THOMPSON, K. A., SIDDOWAY, L. A., DUFF, H. J., WOOSLEY, R. L. AND RODEN, D. M.: Concentration-dependent pharmacologic properties of sotatol. Am. J. Cardiol. 57: 1160-1165, 1986.
28. ZHANG, Z. FOLLMER, C. H., SARMA, J. S. M., CHEN, F. AND SINGH, B. N.: Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: Block of delayed outward potassium current. J. Pharmacol. Exp. Ther. 263: 40-48, 1992.